Catheter Precision (VTAK) Acquisitions (2023 - 2026)

Catheter Precision (VTAK) reported Acquisitions of $1.2 million for Q1 2026, up 101.67% quarter-over-quarter from -$72.5 million in Q4 2023.

Catheter Precision (VTAK) Acquisitions (2023 - 2026) Analysis & Trends

Catheter Precision (VTAK) has 2 years of Acquisitions data on file, last reported at $1.2 million in Q1 2026.

Acquisitions for Q1 2026 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY), and the FY2023 annual result was $15000.0, changed N/A from the prior year.
Acquisitions rose to $1.2 million in Q1 2026 per VTAK's latest filing, from -$72.5 million in the prior quarter.
Over five years, Acquisitions peaked at $72.6 million in Q3 2023 and troughed at -$72.5 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-268.10 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.30 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Catheter Precision	921,210.28	109,210.28	390,000.00	1.21 Mn

Download Data